To provide safety analytic support for cder.

Ended Awarded Last action

Contract number
75F40122F19026
Awardee
Awarding agency
Obligated
$1,819,358

Award facts

Contract value 100% obligated
$1,819,357.82 Current and potential, with all options
Completion date 100% complete
  • Current, with exercised options
  • Potential, with all options
Contracting staff
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Labor Hours
Place of performance
Silver Spring, MD 20993, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Close Out P00006 -$29,745
Funding Only Action P00005 · P00005 - three (3) month extension and additional funds $200,181
Other Administrative Action P00004 $0
Other Administrative Action P00003 · The purpose of this modification is to increase the amount of labor hours by 2,456. All other terms and conditions remain unchanged. $449,748
Exercise an Option P00002 · Exercise option 1 for clinical data safety analysis $599,714
Other Administrative Action P00001 · Add lcat -- to provide safety analytic support for cder. $0
Original award $599,460

About this award

Written by GovTribe AI ·

The Food and Drug Administration issued a BPA call to IBM under the Regulatory Review Support Services parent BPA on April 15, 2022, to provide safety analytic support for CDER, with a ceiling value of $1,819,357.82. This call represents a three-month extension with additional funds, with ultimate completion set for April 14, 2024.

Work is performed at Silver Spring, Maryland. IBM self-performed across the call's reported period, with no subcontractors in FY2024. Service Contract Inventory data shows labor activity of 2.2 FTEs and 4,562 contractor hours in the most recent fiscal year (FY2024), invoiced at $818 thousand. The derived government-paid hourly rate rose from $154.88 in FY2022 to $179.29 in FY2024, reflecting a year-over-year upward trend. FY2023 reported the highest invoiced volume at $838 thousand across 2.5 FTEs and 5,157 hours.

Subawards

Subcontractor Amount Awarded
Temple University-Of The Commonwealth System Of Higher Education THE ALS FUNCTIONAL RATINGS SCALE-REVISED CLINICAL OUTCOME ASSESSMENT REMOTE-USE EQUIVALENCY STUDY. Subcontract 26-312-0217597 Mod 2 $12,360
University Of Kansas Medical Center Research Institute, Inc. THE ALS FUNCTIONAL RATINGS SCALE-REVISED CLINICAL OUTCOME ASSESSMENT REMOTE-USE EQUIVALENCY STUDY. Subcontract 15-312-0217597 Mod 2 $13,300
The Regents Of The University Of Colorado THE ALS FUNCTIONAL RATINGS SCALE-REVISED CLINICAL OUTCOME ASSESSMENT REMOTE-USE EQUIVALENCY STUDY. Subcontract 19-312-0217597 Mod 2 $18,620
The Regents Of The University Of Colorado THE ALS FUNCTIONAL RATINGS SCALE-REVISED CLINICAL OUTCOME ASSESSMENT REMOTE-USE EQUIVALENCY STUDY. Subcontract 19-312-0217597 Initial Award $33,074
University Of Kansas Medical Center Research Institute, Inc. THE ALS FUNCTIONAL RATINGS SCALE-REVISED CLINICAL OUTCOME ASSESSMENT REMOTE-USE EQUIVALENCY STUDY. Subcontract 15-312-0217597 Initial Award $33,074

Quick answers

Who was awarded contract 75F40122F19026?

75F40122F19026 was awarded to International Business Machines Corporation by Food and Drug Administration (Department of Health and Human Services) on April 15, 2022.

How much is contract 75F40122F19026 worth?

The government has obligated $1,819,358 on 75F40122F19026.

Is contract 75F40122F19026 an order under another contract?

Yes. 75F40122F19026 is a BPA call under GS35F110DA-75F40119A10019, a blanket purchase agreement, on Regulatory Review Support Services.

Was contract 75F40122F19026 competed?

The extent of competition for 75F40122F19026 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login